Updates from The Motley Fool

Latest updates on Arena Pharmaceuticals, Inc. from Fool.com.


Stock Performance

ARNA vs. S&P 500 | 2 Year Performance
ARNA 1-Day Stock Chart
ARNA 5-Day Stock Chart
ARNA 1-Month Stock Chart
ARNA 3-Month Stock Chart
ARNA 6-Month Stock Chart
ARNA 1-Year Stock Chart
ARNA 2-Year Stock Chart
ARNA 5-Year Stock Chart
View Interactive ARNA Charts
Sponsored by

Key Data Points

Primary metrics and data points about Arena Pharmaceuticals, Inc..
Current Price: $1.59
Prev Close: $1.63
Open: $1.63
Bid: $1.53
Ask: $1.62
Day's Range: $1.59 - $1.67
52wk Range: $1.30 - $5.12
Volume: 1,571,694
Avg Vol 1,788,956
Market Cap: $385.65M
P/E (ttm): -3.70
EPS (ttm): -$0.44
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Arena Pharmaceuticals, Inc..
CAPS Rating 2 out of 5
 
766 Outperform
70 Underperform
CAPS All Stars
 
100 Outperform
16 Underperform

How do you think Arena Pharmaceuticals, Inc. will perform against the market?



You pick for Arena Pharmaceuticals, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Jackie Lief, CEO

34% Approve

Based on 4 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Arena Pharmaceuticals, Inc..

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers